You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新華醫療(600587.SH):擬定增募資不超12.84億元 用於高端精密微創手術器械生產擴建項目等
格隆匯 12-30 19:15

格隆匯12月30日丨新華醫療(600587.SH)公佈非公開發行股票預案,本次非公開發行股份數量不超過發行前公司總股本的30%,即不超過121,928,427股(含本數)。

本次非公開發行股票的發行對象為包括山東健康在內的不超過35名特定投資者。山東健康於2021年12月30日與公司簽訂了《山東新華醫療器械股份有限公司向山東頤養健康產業發展集團有限公司非公開發行股份之股份認購協議》,同意以現金方式認購本次發行的股份,認購股份數量不低於本次發行股票總數的28.77%。

本次發行的發行價格不低於定價基準日前20個交易日股票交易均價的80%。

本次非公開發行募集資金總額不超過人民幣12.84億元(含本數),扣除發行費用後擬用於基於柔性加工生產線的智能製造及配套項目、高端精密微創手術器械生產擴建項目、製藥小容量製劑智能化生產裝備產業化項目、新華醫療高端醫療裝備研發檢驗檢測中心項目、高性能放射治療設備及醫學影像產品產業化建設項目、實驗室系列產品產業化項目以及補充流動資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account